Association Health Plans Act
Summary
S.1847 is an early-stage bill expanding self-funded association health plans for small businesses, structurally negative for fully insured commercial carriers. The bill has no dollar authorization and remains in committee with only 6 sponsors — near-term passage probability is low. Real market data shows large health insurers (UNH, HUM, CVS, CNC) surging 15-55% in the last 30 days, but this rally is unrelated to S.1847 and driven by broader sector dynamics.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.S.1847 is a structural negative for fully insured commercial carriers but has zero near-term legislative momentum — 11 months with no action since referral to committee.
- 2.The 30-day rally in health insurers (UNH +41.6%, CNC +54.9%) is unrelated to S.1847; if anything, the bill's reintroduction would be a selling opportunity for the sector.
- 3.No dollar appropriation; pure regulatory change. Passage probability in the 119th Congress is low given only 6 total sponsors and no committee markups.
Market Implications
Health insurer stocks have rallied dramatically in the last 30 days: UNH at $366.77 (+41.6%), HUM at $229.72 (+35.9%), CNC at $49.57 (+54.9%), MOH at $185.46 (+38.4%). None of this move is driven by S.1847, which is structurally bearish for these same names but lacks passage momentum. Traders should not conflate the sector rally with AHP legislation risk. If S.1847 gained committee traction, it would be a near-term headwind for $CNC and given their exposure to the small group risk pool.
Full Analysis
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
What the bill does
Regulatory exemption allowing small business association health plans (AHPs) to self-fund under relaxed ERISA standards, bypassing ACA market rules and state benefit mandates.
Who must act
Small employers (under 50 employees), trade associations, and professional groups forming self-funded AHPs.
What happens
Lower premium costs for participating small businesses, driving migration of ~3-5% of the small group (2-50 lives) commercial risk pool away from fully insured exchange and off-exchange plans over 3-5 years if enacted.
Stock impact
Aetna (CVS Health) is a top-3 fully insured small group carrier. Membership losses in a ~$15B Aetna commercial block would reduce premium revenue and PBM drug claims flowing through Caremark; 1% membership loss = ~$150M premium impact.
What the bill does
Regulatory exemption allowing small business association health plans (AHPs) to self-fund under relaxed ERISA standards, bypassing ACA market rules and state benefit mandates.
Who must act
Small employers (under 50 employees), trade associations, and professional groups forming self-funded AHPs.
What happens
Lower premium costs for participating small businesses, driving migration of ~3-5% of the small group (2-50 lives) commercial risk pool away from fully insured exchange and off-exchange plans over 3-5 years if enacted.
Stock impact
Centene is the largest ACA exchange carrier (Ambetter) with ~20% market share; small group and exchange populations overlap significantly. Self-funded AHP migration would shrink the individual and small group risk pool that Centene dominates, reducing premium revenue and raising average risk pool morbidity.
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Association Health Plans Act
I CAN Act
Protecting Health Care and Lowering Costs Act of 2025
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $895M Department of Veterans Affairs Contract
Medicare for All Act
Putting Patients First Healthcare Freedom Act
Medicare Advantage Prompt Pay Act
Veterans’ ACCESS Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.